Epidemiology, Diagnosis, and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

    November 2011 in “ Human reproduction update
    Héctor F. Escobar-Morreale, Enrico Carmina, Didier Dewailly, Alessandra Gambineri, Fahrettin Keleştimur, Paolo Moghetti, Michel Pugeat, Jie Qiao, Chandrika N. Wijeyaratne, Selma F. Witchel, Robert J. Norman
    Image of study
    TLDR Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.
    The document reviewed the epidemiology, pathophysiology, diagnosis, and management of hirsutism, a condition characterized by excessive terminal hair growth in women. The prevalence of hirsutism is approximately 10% across most populations, with a notably lower incidence in Far-East Asian women. Polycystic ovary syndrome (PCOS) is the most common cause, but hirsutism can also indicate serious conditions, such as life-threatening tumors. The paper emphasizes the importance of evidence-based diagnostic and treatment approaches that focus on both improving the symptoms of hirsutism and addressing its underlying causes. Given that hirsutism typically requires long-term management, the document provides guidelines for the etiological diagnosis and management of this common condition.
    Discuss this study in the Community →

    Research cited in this study

    45 / 45 results

    Related Community Posts Join

    6 / 23 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community AA and Hirsutism but T levels are normal

      in Female  6 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 4 weeks ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 8 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    4 / 4 results